Labianca R, Beretta GD, Kildani B, Milesi L, Merlin F, Mosconi S, Pessi MA, Prochilo T, Quadri A, Gatta G, De Braud F, Wils J. Colon cancer. Crit Rev Oncol Hematol. 2010;74(2):106–33. https://doi.org/10.1016/j.critrevonc.2010.01.010.

Article  PubMed  Google Scholar 

“Cancer of the Colon and Rectum - Cancer Stat Facts.” SEER, National Cancer Institute, https://seer.cancer.gov/statfacts/html/colorect.html

Rassy E, Parent P, Lefort F, Boussios S, Baciarello G, Pavlidis N. New rising entities in cancer of unknown primary: is there a real therapeutic benefit? Crit Rev Oncol Hematol. 2020;147:2–3. https://doi.org/10.1016/j.critrevonc.2020.102882.

Article  Google Scholar 

Aghabozorgi AS, Bahreyni A, Soleimani A, Bahrami A, Khazaei M, Ferns GA, Avan A, Hassanian SM. Role of adenomatous polyposis coli (APC) gene mutations in the pathogenesis of colorectal cancer; current status and Perspectives. Biochimie. 2019;157:64–71. https://doi.org/10.1016/j.biochi.2018.11.003.

Article  CAS  PubMed  Google Scholar 

Valenta T, Hausmann G, Basler K. The many faces and functions of β-catenin. EMBO J. 2012;31(12):2714–36. https://doi.org/10.1038/emboj.2012.150.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim Y, Petko Z, Dzieciatkowski S, Lin L, Ghiassi M, Stain S, Chapman WC, Washington MK, Willis J, Markowitz SD, Grady WM. CPG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer. Genes Chromosom Cancer. 2006;45(8):781–9. https://doi.org/10.1002/gcc.20341.

Article  CAS  PubMed  Google Scholar 

Minamoto T, Sawaguchi K, Ohta T, Itoh T, Mai M. Superficial-type adenomas and adenocarcinomas of the colon and rectum: a comparative morphological study. Gastroenterology. 1994;106(6):1436–43. https://doi.org/10.1016/0016-5085(94)90395-6.

Article  CAS  PubMed  Google Scholar 

Ahmed M. Colon cancer: a clinician’s perspective in 2019. Gastroenterol Res. 2020;13(1):1–10. https://doi.org/10.14740/gr1239.

Article  Google Scholar 

Chakrabarti S, Peterson CY, Sriram D, Mahipal A. Early stage colon cancer: current treatment standards, evolving paradigms, and future directions. World J Gastrointest Oncol. 2020;12(8):808–32. https://doi.org/10.4251/wjgo.v12.i8.808.

Article  PubMed  PubMed Central  Google Scholar 

Osterman E, Glimelius B. Recurrence risk after up-to-date colon cancer staging, surgery, and pathology: analysis of the entire Swedish population. Dis Colon Rectum. 2018;61(9):1016–25. https://doi.org/10.1097/dcr.0000000000001158.

Article  PubMed  Google Scholar 

Osseis M, Nehmeh WA, Rassy N, Derienne J, Noun R, Salloum C, Rassy E, Boussios S, Azoulay D. Surgery for T4 colorectal cancer in older patients: determinants of outcomes. J Pers Med. 2022;12(9):1534. https://doi.org/10.3390/jpm12091534.

Article  PubMed  PubMed Central  Google Scholar 

Simmonds P, Best L, George S, Baughan C, Buchanan R, Davis C, Fentiman I, Gosney M, Northover J, Williams C. Surgery for colorectal cancer in elderly patients: a systematic review. The Lancet. 2000;356(9234):968–74. https://doi.org/10.1016/S0140-6736(00)02713-6.

Article  Google Scholar 

Wang J, Li S, Liu Y, Zhang C, Li H, Lai B. Metastatic patterns and survival outcomes in patients with stage IV colon cancer: a population-based analysis. Cancer Med. 2019;9(1):361–73. https://doi.org/10.1002/cam4.2673.

Article  PubMed  PubMed Central  Google Scholar 

Monahan BV, Patel T, Poggio JL. Stage IV colorectal cancer at initial presentation versus progression during and after treatment, differences in management: management differences for initial presentation versus progression of disease after initial treatment. Clin Colon Rectal Surg. 2023;37(02):108–13. https://doi.org/10.1055/s-0043-1761626.

Article  PubMed  PubMed Central  Google Scholar 

Banerjee A, Pathak S, Subramanium VD, Dharanivasan G, Murugesan R, Verma RS. Strategies for targeted drug delivery in treatment of colon cancer: current trends and future perspectives. Drug Discov Today. 2017;22(8):1224–32. https://doi.org/10.1016/j.drudis.2017.05.006.

Article  CAS  PubMed  Google Scholar 

Webster RM. The immune checkpoint inhibitors: where are we now? Nat Rev Drug Discov. 2014;13(12):883–4. https://doi.org/10.1038/nrd4476.

Article  CAS  PubMed  Google Scholar 

Lorenzi M, Amonkar M, Zhang J, Mehta S, Liaw K. Epidemiology of microsatellite instability high (MSI-H) and deficient mismatch repair (dmmr) in solid tumors: a structured literature review. J Oncol. 2020;2020(9):1–17. https://doi.org/10.1155/2020/1807929.

Article  CAS  Google Scholar 

Oliveira AF, Bretes L, Furtado I. Review of PD-1/PD-L1 inhibitors in metastatic dMMR/MSI-H colorectal cancer. Front Oncol. 2019;9:14. https://doi.org/10.3389/fonc.2019.00396.

Article  Google Scholar 

Adeleke S, Haslam A, Choy A, Diaz-Cano S, Galante JR, Mikropoulos C, Boussios S. Microsatellite instability testing in colorectal patients with Lynch syndrome: lessons learned from a case report and how to avoid such pitfalls. Personal Med. 2022;19(4):277–86. https://doi.org/10.2217/pme-2021-0128.

Article  CAS  Google Scholar 

Shan T, Chen S, Wu T, Yang Y, Li S, Chen X. PD-L1 expression in colon cancer and its relationship with clinical prognosis. Int J Clin Exp Pathol. 2019 May 1;12(5):1764–1769. Erratum in: Int J Clin Exp Pathol. 2022 Mar 15;15(3):155–156. PMID: 31933995; PMCID: PMC6947132.

Trinh A, Trumpi K, De Sousa E, Melo F, Wang X, de Jong JH, Fessler E, Kuppen PJK, Reimers MS, Swets M, Koopman M, Nagtegaal ID, Jansen M, Hooijer GKJ, Offerhaus GJA, Kranenburg O, Punt CJ, Medema JP, Markowetz F, Vermeulen L. Practical and robust identification of molecular subtypes in colorectal cancer by immunohistochemistry. Clin Cancer Res. 2017;23(2):387–98. https://doi.org/10.1158/1078-0432.CCR-16-0680.

Article  CAS  PubMed  Google Scholar 

Hirano H, Takashima A, Hamaguchi T, Shida D, Kanemitsu Y. Current status and perspectives of immune checkpoint inhibitors for colorectal cancer. Jpn J Clin Oncol. 2020;51(1):10–9. https://doi.org/10.1093/jjco/hyaa200.

Article  Google Scholar 

Manz SM, Losa M, Fritsch R, Scharl M. Efficacy and side effects of immune checkpoint inhibitors in the treatment of colorectal cancer. Ther Adv Gastroenterol. 2021;14:175628482110020. https://doi.org/10.1177/17562848211002018.

Article  CAS  Google Scholar 

Casak SJ, Marcus L, Fashoyin-Aje L, Mushti SL, Cheng J, Shen Y, Pierce WF, Her L, Goldberg KB, Theoret MR, Kluetz PG, Pazdur R, Lemery SJ. FDA approval summary: Pembrolizumab for the first-line treatment of patients with MSI-H/DMMR advanced unresectable or metastatic colorectal carcinoma. Clin Cancer Res. 2021;27(17):4680–4. https://doi.org/10.1158/1078-0432.ccr-21-0557.

Article  CAS  PubMed  PubMed Central  Google Scholar 

André T, Shiu K, Kim TW, Jensen BV, Jensen LH, Punt C, Smith D, Garcia-Carbonero R, Benavides M, Gibbs P, De La Fouchardiere C, Rivera F, Elez E, Bendell J, Le DT, Yoshino T, Van Cutsem E, Yang P, Farooqui MZ, Diaz LA. Pembrolizumab in microsatellite-instability–high advanced colorectal cancer. N Engl J Med. 2020;383(23):2207–18. https://doi.org/10.1056/nejmoa2017699.

Article  CAS  PubMed  Google Scholar 

Overman MJ, McDermott R, Leach JL, Lonardi S, Lenz H, Morse MA, Desai J, Hill A, Axelson M, Moss RA, Goldberg MV, Cao ZA, Ledeine J, Maglinte GA, Kopetz S, André T. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (checkmate 142): an open-label, multicentre, phase 2 study. Lancet Oncol. 2017;18(9):1182–91. https://doi.org/10.1016/s1470-2045(17)30422-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stein A, Folprecht G. Immunotherapy of colon cancer. Oncol Res Treat. 2018;41(5):282–5. https://doi.org/10.1159/000488918.

Article  CAS  PubMed  Google Scholar 

Graziani G, Tentori L, Navarra P. Ipilimumab: a novel immunostimulatory monoclonal antibody for the treatment of cancer. Pharmacol Res. 2012;65(1):9–22. https://doi.org/10.1016/j.phrs.2011.09.002.

Article  CAS  PubMed  Google Scholar 

Breakstone R. “Colon cancer and immunotherapy—can we go beyond microsatellite instability? Transl Gastroenterol Hepatol. 2021;6:12–12. https://doi.org/10.21037/tgh.2020.03.08.

Article  PubMed  PubMed Central  Google Scholar 

Igaue S, Okuno T, Ishibashi H, Nemoto M, Hiyoshi M, Kawasaki H, Saitoh H, Saitoh M, Akagi K, Yamamoto J. A pathological complete response after nivolumab plus ipilimumab therapy for DNA mismatch repair-deficient/microsatellite instability-high metastatic colon cancer: a case report. Oncol Lett. 2022;24(1):17. https://doi.org/10.3892/ol.2022.13332.

Article